The 2015 WHO classification (updated 2021), neuroendocrine tumors includes: Small cell carcinoma (mixed small cell variant); Neuroendocrine large cell carcinoma (mixed large cell variant); Carcinoid tumors (typical and atypical); Pre-infiltrating lesions (diffuse pulmonary neuroendocrine hyperplasia).